Sovran Advisors, LLC Abb Vie Inc. Transaction History
Sovran Advisors, LLC
- $954 Billion
- Q2 2025
A detailed history of Sovran Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sovran Advisors, LLC holds 5,083 shares of ABBV stock, worth $958,247. This represents 0.1% of its overall portfolio holdings.
Number of Shares
5,083
Previous 3,519
44.44%
Holding current value
$958,247
Previous $609 Million
58.46%
% of portfolio
0.1%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
4,251Shares Held
1.27BCall Options Held
16.6MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA174MShares$32.8 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.7 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.1 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.3 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.76 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $333B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...